Synergy Pharma (SGYP) Presents Results from Study Examining Patient and Physician Perceptions and Experiences with IBS-C
Tweet Send to a Friend
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) announced today new findings highlighting the frustration of patients suffering from irritable bowel syndrome with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
